This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Ampio Pharmaceuticals Inc (AMPE)

AMEX: Health Care

Company Cash Flow
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash Flow From Operating Activities
Net Income (Loss) -39.05M -24.53M -11.59M -18.36M
Operating Gains/Losses 28.68K 0.00 0.00 0.00
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables 0.00 0.00 0.00 5.71K
(Increase) Decrease in Inventories 0.00 0.00 0.00 0.00
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables 1.02M 699.45K 570.50K 166.17K
(Decrease) Increase In Other Current Liabilities -286.39K 522.06K 0.00 -529.48K
(Increase) Decrease In Other Working Capital 893.95K -50.00K -50.00K 397.22K
Other Non-Cash Items 7.88M 4.05M 1.42M 9.13M
Net Cash From Continuing Operations -30.74M -19.13M -9.72M -9.13M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities -30.74M -19.13M -9.72M -9.13M
Sale of Property, Plant & Equipment 2.38K 0.00 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 0.00 0.00
Purchases of Property, Plant & Equipment -8.67M -1.64M 0.00 -84.70K
Acquisitions 0.00 0.00 0.00 0.00
Purchases of Short-Term Investments 0.00 0.00 0.00 0.00
Other Cash from Investing Activities 8.00K -23.86K 15.00K -35.00K
Cash Provided by Financing Activities
Net Cash From Investing Activities -8.66M -1.67M 15.00K -119.70K
Issuance of Debt 0.00 0.00 0.00 382.00K
Cash Used for Financing Activities
Issuance of Capital Stock 68.41M 30.40M 17.54M 22.44M
Repayment of Long-Term Debt 0.00 0.00 0.00 -100.00K
Repurchase of Capital Stock 0.00 -672.21K 0.00 0.00
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net -5.00M -297.77K -1.52M -2.78M
Net Cash From Financing Activities 63.41M 29.43M 16.02M 19.94M
Effect of Exchange Rate Changes 0.00 0.00 0.00 0.00
Net Change in Cash & Cash Equivalents 24.01M 8.63M 6.32M 10.69M

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

AMPE Ampio Pharmaceuticals Inc

Chart of AMPE

Analysts Ratings for AMPE

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 0 0 0 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

AMPE Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs